Insider Buy/Sell Details for the Healthcare Sector — March 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1861)
TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)
Jover Placid — See "Remarks"
Shares
14,150
Price
$31.67
Total Value
$448.11K
Shares Held After
6,774
% of Holdings
67.6%
TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)
Hughes Eric A — See "Remarks"
Shares
9,533
Price
$31.67
Total Value
$301.89K
Shares Held After
107,711
% of Holdings
8.1%
Xencor Inc (XNCR)
Desjarlais John R — SR. VICE PRESIDENT & CSO
Shares
4,118
Price
$11.25
Total Value
$46.31K
Shares Held After
266,333
% of Holdings
1.5%
TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)
Daniell Richard — EVP, Europe Commercial
Shares
17,295
Price
$31.67
Total Value
$547.70K
Shares Held After
85,755
% of Holdings
16.8%
Metagenomi Therapeutics, Inc. (MGX)
Wein Matthew — Title: General Counsel, Compliance Officer and Corporate Secretary
Shares
482
Price
$1.60
Total Value
$771.20
Shares Held After
114,549
% of Holdings
0.4%
CASTLE BIOSCIENCES INC (CSTL)
Cole G Bradley — Director
Shares
2,655
Price
$28.51
Total Value
$75.69K
Shares Held After
19,309
% of Holdings
12.1%
CASTLE BIOSCIENCES INC (CSTL)
Cole G Bradley — Director
Shares
4,748
Price
$28.44
Total Value
$135.03K
Shares Held After
21,964
% of Holdings
17.8%
Rapport Therapeutics, Inc. (RAPP)
Gault Cheryl — Chief Operating Officer
Shares
2,014
Price
$28.93
Total Value
$58.27K
Shares Held After
169,914
% of Holdings
1.2%
TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)
Francis Richard D — President and CEO
Shares
20,025
Price
$31.67
Total Value
$634.16K
Shares Held After
1,170,639
% of Holdings
1.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
587
Price
$487.98
Total Value
$286.45K
Shares Held After
130
% of Holdings
81.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,199
Price
$487.02
Total Value
$583.94K
Shares Held After
717
% of Holdings
62.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
798
Price
$486.20
Total Value
$387.99K
Shares Held After
1,916
% of Holdings
29.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,625
Price
$485.00
Total Value
$1.27M
Shares Held After
2,714
% of Holdings
49.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,728
Price
$484.05
Total Value
$836.44K
Shares Held After
5,339
% of Holdings
24.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,293
Price
$482.93
Total Value
$624.42K
Shares Held After
7,067
% of Holdings
15.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
510
Price
$482.05
Total Value
$245.84K
Shares Held After
8,360
% of Holdings
5.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
481
Price
$480.56
Total Value
$231.15K
Shares Held After
8,870
% of Holdings
5.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
279
Price
$479.89
Total Value
$133.89K
Shares Held After
9,351
% of Holdings
2.9%
CASTLE BIOSCIENCES INC (CSTL)
Stokes Frank — Chief Financial Officer
Shares
6,001
Price
$27.98
Total Value
$167.91K
Shares Held After
60,085
% of Holdings
9.1%
SUPERNUS PHARMACEUTICALS, INC. (SUPN)
GEMAYEL GEORGES — Director
Shares
10,000
Price
$53.71
Total Value
$537.10K
Shares Held After
28,159
% of Holdings
26.2%
Quantum-Si Inc (QSI)
Kummeth Charles R. — Director
Shares
500,000
Price
$0.92
Total Value
$459.80K
Shares Held After
855,000
% of Holdings
58.5%
TANDEM DIABETES CARE INC (TNDM)
Novara Mark David — EVP & CHIEF COMMERCIAL OFFICER
Shares
2
Price
$22.81
Total Value
$45.62
Shares Held After
35,969
% of Holdings
0.0%
Quantum-Si Inc (QSI)
Dowdy Paula — Director
Shares
109,890
Price
$0.95
Total Value
$104.45K
Shares Held After
269,107
% of Holdings
40.8%
PTC THERAPEUTICS, INC. (PTCT)
Golden Lee Scott — EVP & CHIEF MEDICAL OFFICER
Shares
10,000
Price
$63.38
Total Value
$633.80K
Shares Held After
79,944
% of Holdings
11.1%
Entera Bio Ltd. (ENTX)
Ellis Sean — Director
Shares
10,000
Price
$1.23
Total Value
$12.30K
Shares Held After
188,098
% of Holdings
5.3%
ADMA BIOLOGICS, INC. (ADMA)
ELMS STEVE — Director
Shares
7,000
Price
$15.67
Total Value
$109.69K
Shares Held After
2,038,730
% of Holdings
0.3%
Alphatec Holdings, Inc. (ATEC)
Marshall Tyson Eliot — GENERAL COUNSEL & CORP. SEC.
Shares
88,835
Price
$12.49
Total Value
$1.11M
Shares Held After
559,459
% of Holdings
13.7%
Cullinan Therapeutics, Inc. (CGEM)
Michaelson Jennifer — Chief Scientific Officer
Shares
8,000
Price
$15.68
Total Value
$125.44K
Shares Held After
170,844
% of Holdings
4.5%
BIOLIFE SOLUTIONS INC (BLFS)
Foster Karen A. — Chief Quality and Operations
Shares
96,923
Price
$20.15
Total Value
$1.95M
Shares Held After
113,742
% of Holdings
46.0%
ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
Hamilton James C — Chief Medical Officer
Shares
10,000
Price
$64.19
Total Value
$641.90K
Shares Held After
236,958
% of Holdings
4.0%
PROCEPT BioRobotics Corp (PRCT)
Desai Antal Rohit — Director
Shares
24,748
Price
$26.41
Total Value
$653.53K
Shares Held After
167,246
% of Holdings
14.8%
PROCEPT BioRobotics Corp (PRCT)
Desai Antal Rohit — Director
Shares
142,498
Price
$25.44
Total Value
$3.63M
Shares Held After
142,498
% of Holdings
100.0%
Surgery Partners, Inc. (SGRY)
Webb William Trenton — American Group President
Shares
1,794
Price
$13.86
Total Value
$24.86K
Shares Held After
72,455
% of Holdings
2.4%
NewAmsterdam Pharma Co N.V. (NAMS)
Kastelein Johannes Jacob Pieter — Director
Shares
104,467
Price
$30.30
Total Value
$3.17M
Shares Held After
69,302
% of Holdings
60.1%
Adaptive Biotechnologies Corp (ADPT)
LO FRANCIS — Chief People Officer
Shares
38,074
Price
$15.09
Total Value
$574.54K
Shares Held After
321,967
% of Holdings
10.6%
GRAIL, Inc. (GRAL)
Freidin Aaron — Chief Financial Officer
Shares
655
Price
$53.01
Total Value
$34.72K
Shares Held After
308,967
% of Holdings
0.2%
GRAIL, Inc. (GRAL)
RAGUSA ROBERT P — Director
Shares
980
Price
$53.01
Total Value
$51.95K
Shares Held After
649,545
% of Holdings
0.2%
GRAIL, Inc. (GRAL)
Ofman Joshua J. — President
Shares
690
Price
$53.01
Total Value
$36.58K
Shares Held After
435,818
% of Holdings
0.2%
CERUS CORP (CERS)
Green Kevin Dennis — Chief Financial Officer
Shares
55,225
Price
$2.06
Total Value
$113.90K
Shares Held After
1,195,891
% of Holdings
4.4%
CERUS CORP (CERS)
Benjamin Richard J — Chief Medical Officer
Shares
61,233
Price
$2.06
Total Value
$126.31K
Shares Held After
943,762
% of Holdings
6.1%
Heartflow, Inc. (HTFL)
Cullivan Julie A — Director
Shares
9,122
Price
$25.00
Total Value
$228.05K
Shares Held After
27,291
% of Holdings
25.1%
Bicara Therapeutics Inc. (BCAX)
Mazumdar Claire — Director
Shares
1,786
Price
$18.74
Total Value
$33.46K
Shares Held After
339,392
% of Holdings
0.5%
Sionna Therapeutics, Inc. (SION)
Fitzpatrick Jennifer — Chief Legal Officer
Shares
10,250
Price
$33.86
Total Value
$347.02K
Shares Held After
0
% of Holdings
100.0%
Schrödinger, Inc. (SDGR)
Herman Jenny — CAO
Shares
775
Price
$12.85
Total Value
$9.96K
Shares Held After
35,412
% of Holdings
2.1%
Schrödinger, Inc. (SDGR)
Jain Rachit — EVP & CFO
Shares
1,631
Price
$12.90
Total Value
$21.03K
Shares Held After
52,596
% of Holdings
3.0%
HENRY SCHEIN INC (HSIC)
LASKAWY PHILIP A — Director
Shares
2,844
Price
$80.36
Total Value
$228.54K
Shares Held After
21,961
% of Holdings
11.5%
Dyne Therapeutics, Inc. (DYN)
Kerr Douglas — Chief Medical Officer
Shares
904
Price
$14.90
Total Value
$13.47K
Shares Held After
171,606
% of Holdings
0.5%
Dyne Therapeutics, Inc. (DYN)
Cox John — Director
Shares
2,732
Price
$14.90
Total Value
$40.71K
Shares Held After
374,145
% of Holdings
0.7%
Elevance Health, Inc. (ELV)
COLLIS STEVEN H — Director
Shares
3,000
Price
$289.84
Total Value
$869.52K
Shares Held After
3,639
% of Holdings
82.4%
ProMIS Neurosciences Inc. (PMN)
Williams Eugene — Director
Shares
2,000
Price
$24.40
Total Value
$48.80K
Shares Held After
12,397
% of Holdings
16.1%
Showing 1001–1050 of 1861 transactions (page 21 of 38)